LeMaitre Vascular officer proposes $313K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LeMaitre Vascular Inc. officer Trent G. Kamke's Form 144 reports a proposed sale of 2,928 common shares, with an aggregate market value of $313,286.92 and an approximate sale date of May 8, 2026. It also lists Kamke's sales during the past three months: 2,625 shares on March 11, 2026, for gross proceeds of $284,812.50, and 1,044 shares on February 27, 2026, for gross proceeds of $115,142.76.
Key Figures
Key Terms
Aggregate Market Value financial
Gross Proceeds financial
Restricted stock vesting under a registered plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What recent LMAT stock sales does Trent G. Kamke report?
AI-generated analysis. How Rhea-AI works. Not financial advice.